THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0

作者：

Yamaoka, Kenji ^{[1
]}

Kawaoka, Tomokazu ^{[1
]}

Kosaka, Masanari ^{[1
]}

Johira, Yusuke ^{[1
]}

Shirane, Yuki ^{[1
]}

Miura, Ryoichi ^{[1
]}

Yano, Shigeki ^{[1
]}

Murakami, Serami ^{[1
]}

Amioka, Kei ^{[1
]}

Naruto, Kensuke ^{[1
]}

Ando, Yuwa ^{[1
]}

Kosaka, Yumi ^{[1
]}

Uchikawa, Shinsuke ^{[1
]}

Kodama, Kenichiro ^{[1
]}

Uchida, Takuro ^{[1
]}

Fujino, Hatsue ^{[1
]}

Ono, Atsushi ^{[1
]}

Nakahara, Takashi ^{[1
]}

Murakami, Eisuke ^{[1
]}

Okamoto, Wataru ^{[2
]}

Yamauchi, Masami ^{[1
]}

Miki, Daiki ^{[1
]}

Imamura, Michio ^{[1
]}

Chayama, Kazuaki ^{[3
]}

Aikata, Hiroshi ^{[1
]}

机构：

[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan

[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan

[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4508

引用

页码：S1386 / S1387

页数：2

共 50 条

[31] Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma
Shindoh, Junichi
Kawamura, Yusuke
Kobayashi, Yuta
Kobayashi, Masahiro
Akuta, Norio
Okubo, Satoshi
Suzuki, Yoshiyuki
Hashimoto, Masaji
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7663 - 7672
[32] Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma
Liu, Hong
Gan, Xue-Mei
Sun, Jian-Ming
Yang, Qin
Zhang, Dai-Zhong
Zuo, Yong- Qing
Liu, Feng-Ling
Li, Bo
Tan, Qi-Liang
Zhang, Jun
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
[33] Comparison of the clinical efficacy of donafinil and lenvatinib in the treatment of intermediate and advanced hepatocellular carcinoma
He, Qinzhen
Guo, Mengguang
Ya, Yanhong
Huang, Jinli
Liu, Aiqiu
Jing, Wexiang
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (05): : 3579 - 3585
[34] Combination of Lenvatinib and Proton Beam Therapy in the Management of Patients With Advanced Hepatocellular Carcinoma
Cheng, Jen-yu
Huang, Bing-shen
Chen, Yen-yang
Wang, Chih-chi
Chen, Yen-hao
ANTICANCER RESEARCH, 2023, 43 (03) : 1361 - 1371
[35] Outcome of receiving lenvatinib following immunotherapy in patients with advanced hepatocellular carcinoma.
Gile, Jennifer
Palmer, Mathias Earl
Storandt, Michael H.
Bekaii-Saab, Tanios S.
Tran, Nguyen H.
Mahipal, Amit
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 507 - 507
[36] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
Han, Ji Eun
Kim, Jisu
Cheong, Jae Youn
Kim, Soon Sun
Lim, Sun Gyo
Yang, Min Jae
Noh, Choong-Kyun
Lee, Gil Ho
Eun, Jung Woo
Park, Bumhee
Cho, Hyo Jung
CANCERS, 2024, 16 (02)
[37] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
Cho, Hyo Jung
Han, Ji Eun
Cheong, Jae Youn
Kim, Soon Sun
JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
[38] Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma
Glen, Hilary
FUTURE ONCOLOGY, 2016, 12 (19) : 2195 - 2204
[39] Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma
Rehman, Obaid
Jaferi, Urooj
Padda, Inderbir
Khehra, Nimrat
Atwal, Harshan
Mossabeh, Dina
Bhangu, Ranvir
CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (03) : 249 - 257
[40] Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma
Miyajima, Saori
Tsuji, Kunihiro
Kito, Yosuke
Yoshida, Naohiro
Matsunaga, Kazuhiro
Tsuji, Shigetsugu
Katayanagi, Kazuyoshi
Yonezawa, Miwa
Kubo, Anna
Ushijima, Kahori
Minato, Hiroshi
Doyama, Hisashi
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 187 - 192

← 1 2 3 4 5 →